Work

Supplementary Figure 12 from Engineered SH3-Derived Sherpabodies Function as a Modular Platform for Targeted T-cell Immunotherapy

Year: 2026

Type: supplementary-materials

Abstract: Figure S12. Statistical analysis of fraction of CD62L+CD45RA+ in T cells engineered with constitutive ScFv and SbCAR and inducible SbCAR (related to Figure 5A).

DOI: 10.1158/0008-5472.32707344

Authors: Rogelio A. Hernández-López, Tapio Kesti, Anna R. Mäkelä, Zhe Zhao, Wei Yu, Yurie Tonai, Hector J. Monzo, Kerttu Kalander, Sirpa Leppä, Päivi M. Ojala, Wendell A. Lim, Kalle Saksela

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165006946

Cites:

Cited by:

Related to: 10